Nexpoint Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Nexpoint Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-602,108	Closed	-$45.3M	–	164
2022 Q2	$45.3M	Buy	+602,108	New	+$26.8M	4.03%	5

Nexpoint Asset Management's TPTX Position: Q3 2022 in Review

Nexpoint Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 602,108 shares — an estimated $45.3M sold.

Nexpoint Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $45.3M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Nexpoint Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Nexpoint Asset Management sold 602,108 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $45.3M.
Nexpoint Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Nexpoint Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $45.3M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Nexpoint Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.